2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.
Kamińska K, Świt P, Malek K.
J Anal Toxicol. 2021 Jan 21;44(9):947-956. doi: 10.1093/jat/bkaa022.
The toxicological effects of halogenated naphthalenes: a review of aryl hydrocarbon receptor-mediated (dioxin-like) relative potency factors.
Falandysz J, Fernandes A, Gregoraszczuk E, Rose M.
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2014;32(3):239-72. doi: 10.1080/10590501.2014.938945.
Effects and risk assessment of halogenated bisphenol A derivatives on human follicle stimulating hormone receptor: An interdisciplinary study.
Suteau V, Zuzic L, Hansen DH, Kjølbye LR, Sibilia P, Gourdin L, Briet C, Thomas M, Bourdeaud E, Tricoire-Leignel H, Schiøtt B, Carato P, Rodien P, Munier M.
J Hazard Mater. 2024 Nov 5;479:135619. doi: 10.1016/j.jhazmat.2024.135619. Epub 2024 Aug 29.
2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity.
Poland A, Knutson JC.
Annu Rev Pharmacol Toxicol. 1982;22:517-54. doi: 10.1146/annurev.pa.22.040182.002505.
Halogenated biphenyls: molecular toxicology.
Safe S, Robertson LW, Safe L, Parkinson A, Bandiera S, Sawyer T, Campbell MA.
Can J Physiol Pharmacol. 1982 Jul;60(7):1057-64. doi: 10.1139/y82-151.
Advanced oxidation processes for the removal of mono and polycyclic aromatic hydrocarbons - A review.
Rayaroth MP, Marchel M, Boczkaj G.
Sci Total Environ. 2023 Jan 20;857(Pt 2):159043. doi: 10.1016/j.scitotenv.2022.159043. Epub 2022 Sep 27.
Inhibition of neovascularization by environmental agents.
Ivnitski-Steele I, Walker MK.
Cardiovasc Toxicol. 2005;5(2):215-26. doi: 10.1385/ct:5:2:215.
New Insights into Human Biotransformation of BDE-209: Unique Occurrence of Metabolites of Ortho-Substituted Hydroxylated Higher Brominated Diphenyl Ethers in the Serum of e-Waste Dismantlers.
Ma S, Ren G, Zheng K, Cui J, Li P, Huang X, Lin M, Liu R, Yuan J, Yin W, Peng P, Sheng G, Yu Z.
Environ Sci Technol. 2022 Jul 19;56(14):10239-10248. doi: 10.1021/acs.est.2c02074. Epub 2022 Jul 5.
Influence of the halogen-substituent pattern of fluoronitrobenzenes on their biotransformation and capacity to induce methemoglobinemia.
Cnubben NH, Soffers EM, Peters MA, Vervoort J, Rietjens IM.
Toxicol Appl Pharmacol. 1996 Jul;139(1):71-83. doi: 10.1006/taap.1996.0144.
Sorafenib for the treatment of thyroid cancer: an updated review.
Krajewska J, Handkiewicz-Junak D, Jarzab B.
Expert Opin Pharmacother. 2015 Mar;16(4):573-83. doi: 10.1517/14656566.2015.1005601. Epub 2015 Jan 21.
